sulfa drug (redirected from sulfonamide)

sulfa drug, any of a class of synthetic chemical substances derived from sulfanilamide, or para-aminobenzenesulfonamide. Sulfa drugs are used to treat bacterial infections, although they have largely been replaced for this purpose by antibiotics; some are also used in the treatment of diabetes. Because sulfa drugs were first used to elucidate ways in which substances can interfere with the metabolism of invading microorganisms, they are of historical interest. The parent compound, para-aminobenzenesulfonamide, was synthesized in 1908 by Paul Gelmo, an Austrian industrial chemist. In 1932 the German chemist Gerhard Domagk discovered that the dye Prontosil had antagonistic properties against a wide range of bacteria, and in 1935 it was found that the sulfanilamide portion of the Prontosil molecule was responsible for its antibacterial effect. In 1940 it was shown that sulfanilamide inhibited the action of the physiological substance para-aminobenzoic acid, which bacteria need to synthesize folic acid. The idea that the two substances were antagonists led to a theory of the mechanism of action of drugs: Many chemotherapeutic substances compete with structurally similar substances that are necessary to the metabolism of invading microorganisms. Since sulfanilamide first came into use, more than 150 different derivatives have appeared on the market, chemically modified to achieve more effective antibacterial activity, wider spectrum of microorganisms affected, or more prolonged action. Because of their low cost they are still used in many parts of the world. However, resistance to sulfa drugs has emerged among many microorganisms, especially streptococci, meningococci, and shigella, making them less effective than formerly (see drug resistance). The substances are still used to treat some urinary tract infections, leprosy, and in combination with other drugs, fungal diseases such as toxoplasmosis.

---

sulfa drug

Common term for sulfonamide drug, any member of a class of synthetic antibacterial drugs with a particular chemical structure including both sulfur and nitrogen atoms. Their effectiveness against bacteria was discovered in 1932 by Gerhard Domagk, and they became the first chemical substances systematically used against human bacterial infections. Sulfa drugs inhibit the growth and multiplication of certain bacteria (but do not kill them) by interfering with the synthesis of folic acid. Because of their toxicity and growing bacterial resistance, sulfa drugs are no longer in common use (except for urinary-tract infections, certain forms of malaria, and preventing infection of burns), having been largely superseded by less toxic antibiotics.